• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.

作者信息

Inderlied C B, Lancero M G, Young L S

机构信息

Kuzell Institute for Arthritis and Infectious Diseases, Pacific Presbyterian Medical Center, San Francisco, California.

出版信息

J Antimicrob Chemother. 1989 Sep;24 Suppl A:85-99. doi: 10.1093/jac/24.suppl_a.85.

DOI:10.1093/jac/24.suppl_a.85
PMID:2808217
Abstract

For clinical isolates the MICs of meropenem were significantly lower than the MICs of imipenem, especially against Pseudomonas aeruginosa. Furthermore, meropenem was bactericidal for Pseudomonas spp., including Ps. (Xanthomonas) maltophilia, and staphylococci, with MBCs on average only two-fold above the respective MICs. The bactericidal activity was confirmed by killing curve assays. Strains with high meropenem MICs (greater than or equal to 8 mg/l) were killed by a combination of the carbapenem and amikacin, with kinetics that indicated synergism between the two antimicrobial agents.

摘要

相似文献

1
Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.
J Antimicrob Chemother. 1989 Sep;24 Suppl A:85-99. doi: 10.1093/jac/24.suppl_a.85.
2
Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
J Antimicrob Chemother. 1989 Sep;24 Suppl A:31-45. doi: 10.1093/jac/24.suppl_a.31.
3
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.美罗培南对包括产超广谱β-内酰胺酶肠杆菌科细菌在内的临床分离株的体外活性比较
J Antimicrob Chemother. 1989 Sep;24 Suppl A:133-41. doi: 10.1093/jac/24.suppl_a.133.
4
In-vitro activity of meropenem against clinical isolates obtained in Canada.美罗培南对在加拿大分离出的临床菌株的体外活性。
J Antimicrob Chemother. 1989 Sep;24 Suppl A:47-55. doi: 10.1093/jac/24.suppl_a.47.
5
Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants.美罗培南对临床分离株、β-内酰胺酶产生菌及实验室突变株的抗菌特性。
J Antimicrob Chemother. 1989 Sep;24 Suppl A:197-205. doi: 10.1093/jac/24.suppl_a.197.
6
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.多利培南（S-4661），一种新型碳青霉烯类抗生素：对当代病原体的比较活性，包括杀菌作用和初步体外方法评估。
J Antimicrob Chemother. 2004 Jul;54(1):144-54. doi: 10.1093/jac/dkh298. Epub 2004 Jun 9.
7
In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.美罗培南在意大利一项多中心研究中对临床分离株的体外活性。
J Antimicrob Chemother. 1989 Sep;24 Suppl A:57-72. doi: 10.1093/jac/24.suppl_a.57.
8
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.美罗培南、亚胺培南和哌拉西林/他唑巴坦对 1071 株临床分离菌的体外比较活性：一项法国多中心研究。
BMC Infect Dis. 2010 Mar 18;10:72. doi: 10.1186/1471-2334-10-72.
9
In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.新型碳青霉烯类药物DX-8739、美罗培南和亚胺培南与阿米卡星对多重耐药铜绿假单胞菌的体外相互作用
J Antimicrob Chemother. 1996 Aug;38(2):287-91. doi: 10.1093/jac/38.2.287.
10
The growth-inhibitory properties of meropenem against anaerobes of clinical importance.美罗培南对具有临床重要性厌氧菌的生长抑制特性。
J Antimicrob Chemother. 1989 Sep;24 Suppl A:119-24. doi: 10.1093/jac/24.suppl_a.119.

引用本文的文献

1
Mathematical modelling of the antibiotic-induced morphological transition of Pseudomonas aeruginosa.抗生素诱导铜绿假单胞菌形态转变的数学建模。
PLoS Comput Biol. 2018 Feb 26;14(2):e1006012. doi: 10.1371/journal.pcbi.1006012. eCollection 2018 Feb.
2
Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.美罗培南：抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1995 Jul;50(1):73-101. doi: 10.2165/00003495-199550010-00007.